Emerging treatment options for prostate cancer.
Emerging treatment options for prostate cancer. Expert Rev Anticancer Ther. 2023 06; 23(6):625-631.
PMID: 37101345
First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report.
First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report. Front Oncol. 2023; 13:1126476.
PMID: 36937405
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors.
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors. Clin Cancer Res. 2021 03 15; 27(6):1792-1806.
PMID: 33334906
Pembrolizumab-Induced Cold Agglutinin Disease.
Pembrolizumab-Induced Cold Agglutinin Disease. Am J Case Rep. 2020 Sep 05; 21:e924283.
PMID: 32887867
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Mol Oncol. 2020 08; 14(8):1881-1897.
PMID: 32385899
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression. Clin Cancer Res. 2020 04 15; 26(8):2047-2064.
PMID: 31796516
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2). Clin Cancer Res. 2019 07 15; 25(14):4480-4492.
PMID: 30996073
A Unique Case of Severe Anemia Secondary to Copper Deficiency in an Adult Patient.
A Unique Case of Severe Anemia Secondary to Copper Deficiency in an Adult Patient. Cureus. 2018 Nov 26; 10(11):e3636.
PMID: 30723637
The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer.
The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer. Am J Case Rep. 2018 Oct 18; 19:1241-1244.
PMID: 30333474
Breast Cancer Immunotherapy: An Update.
Breast Cancer Immunotherapy: An Update. Breast Cancer (Auckl). 2018; 12:1178223418774802.
PMID: 29899661